Introduction Management of type 1 diabetes mellitus (T1DM) extends well beyond insulin prescription. Even with optimal adherence, patients commonly experience glycemic variability, uncertainty, and treatment fatigue. Proactively normalizing these challenges as expected and manageable is essential for fostering therapeutic alliance and patient confi
Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes
Link between PCOS, Obesity and Diabetes
479 Reached2 Likes
Risk Factors Associated Glycemia in LBW Infants
2793 Reached2 Comments1 Likes
Autoimmune Hepatitis in Girl with T1DM
1156 Reached2 Comments4 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes